Published in Histopathology on October 01, 2007
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting (TAPG) | NCT03912883
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer (2008) 1.62
Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome. Br J Cancer (2016) 1.20
Multimodal microscopy for automated histologic analysis of prostate cancer. BMC Cancer (2011) 1.06
Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J Cancer (2009) 1.04
The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med (1993) 16.94
A Wilcoxon-type test for trend. Stat Med (1985) 13.22
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet (2005) 11.05
Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet (1993) 7.46
Scleritis-associated uveitis. Ophthalmology (1997) 7.34
Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology (1992) 6.62
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36
Induction of apoptosis in mature T cells by tumour necrosis factor. Nature (1995) 5.26
Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer (1996) 5.24
Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med (1992) 5.18
Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet (2002) 5.04
Change in male:female ratio among newborn infants in Denmark. Lancet (1996) 4.85
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene (2007) 4.81
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet (1986) 4.55
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer (2003) 4.14
Cancer in the European Community and its member states. Eur J Cancer (1990) 3.95
Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys (1998) 3.82
The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology (1986) 3.70
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology (2009) 3.68
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res (1999) 3.58
Natural variation in the human sex ratio. Hum Reprod (1999) 3.27
Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer (2009) 3.27
Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol (2000) 3.26
Mild cervical dyskaryosis: safety of cytological surveillance. Lancet (1992) 3.09
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol (2001) 3.06
Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol (1996) 3.04
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol (2006) 2.94
Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer (2006) 2.76
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol (2001) 2.68
Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene (2007) 2.68
The prognostic value of kidney transplant center report cards. Am J Transplant (2013) 2.64
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol (2002) 2.61
Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res (1999) 2.55
Determining the area under the ROC curve for a binary diagnostic test. Med Decis Making (2001) 2.54
Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol (2012) 2.45
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Rheumatoid arthritis and cancer risk. Eur J Cancer (1996) 2.44
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol (1998) 2.44
Factors predicting recovery of erections after radical prostatectomy. J Urol (2000) 2.44
Severity of scleritis and episcleritis. Ophthalmology (1994) 2.43
Risk factors for urinary incontinence after radical prostatectomy. J Urol (1996) 2.42
Anterior chamber crystals following hyphema. Arch Ophthalmol (1990) 2.39
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep (1987) 2.37
Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg (1984) 2.36
Effect of smoking cessation on cervical lesion size. Lancet (1996) 2.35
Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology (1999) 2.33
Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol (2001) 2.31
Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer (1996) 2.30
Infectious endophthalmitis. Review of 36 cases. Ophthalmology (1982) 2.26
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol (2007) 2.26
Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst (1995) 2.25
Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer (2012) 2.24
Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch Intern Med (2001) 2.20
Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol (1995) 2.19
Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors. J Natl Cancer Inst (1989) 2.19
Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res (1997) 2.16
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer (2012) 2.15
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides. Int J Cancer (1997) 2.13
Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol (1997) 2.10
Cicatricial pemphigoid. Trans Am Ophthalmol Soc (1986) 2.10
A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. N Engl J Med (1991) 2.07
Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol (2000) 2.05
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol (1999) 2.00
Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res (2000) 1.99
Decline in sex ratio at birth after Kobe earthquake. Hum Reprod (1998) 1.98
Small eyes (Sey): a homozygous lethal mutation on chromosome 2 which affects the differentiation of both lens and nasal placodes in the mouse. J Embryol Exp Morphol (1986) 1.98
Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology (1995) 1.98
Accelerated decline in cervical cancer mortality in England and Wales. Lancet (1995) 1.95
Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res (1998) 1.95
Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol (2002) 1.91
Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol (1988) 1.90